Mirum Pharmaceuticals (MIRM) Work In Process (2021 - 2026)

Mirum Pharmaceuticals' Work In Process history runs 6 years deep, the most recent figure standing at $19.5 million for Q1 2026.

• In Q1 2026, Work In Process rose 23.21% year-over-year to $19.5 million; the TTM figure through Mar 2026 stood at $19.5 million (up 23.21% YoY), while the FY2025 annual figure was $18.5 million, up 14.82% from the prior year.
• Work In Process was $19.5 million for Q1 2026 at Mirum Pharmaceuticals, up from $18.5 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $19.5 million in Q1 2026 to a low of $553000.0 in Q1 2022.
• Historically, Work In Process has averaged $11.3 million across 5 years, with a median of $10.8 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Work In Process jumped 1072.51% in 2023, then climbed 14.82% in 2025.
• A 5-year view of Work In Process shows it stood at $5.4 million in 2022, then jumped by 84.51% to $9.9 million in 2023, then jumped by 62.96% to $16.1 million in 2024, then climbed by 14.82% to $18.5 million in 2025, then grew by 5.49% to $19.5 million in 2026.
• The last three Work In Process figures came in at $19.5 million (Q1 2026), $18.5 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.